19 years of professional experience 

I am a honorary appointee Visiting Professor at University College of London (UCL) under the Gene Therapy program of the Institute of Child Health (ICH) of the Great Ormond Street Hospital (GOSH). I am also directing a R&D department for the gene therapy company SANA Biotechnology in Cambridge MA, US

Recent Relevant Work Experience:

I directed the vector safety team for the Gene Therapy program at Boston Children's Hospital/Dana Farber Cancer Institute. I also led a research laboratory at Harvard Medical School investigating the properties of stem cell gene therapy products and their in vivo dynamics upon infusion in humans.

I generated the safety data for the marketing authorization of Strimvelis™, the first commercially approved ex vivo stem cell gene therapy in the world, distributed by GlaxoSmithKline (GSK). I was also a consultant of GSK for the safety of lentiviral gene therapy for Wiskott Aldrich Syndrome. 

Career path:

Medical Biotechnology degree

Ph.D. in Cellular and Molecular Biology 

Post-Doc fellow

Project Leader

Group Leader

Faculty

Assistant Professor

Director/ Honorary Senior Research Associate

Senior Director/ Honorary Senior Research Associate

Executive Director/ Visiting Professor

Previous International working experiences at: 

- National Institutes of Health (NIH) (Bethesda,US) 

- Nationales Zentrum für Tumorerkrankungen (NCT)

Deutsches Krebsforschungszentrum (DKFZ)(Heidelberg,Germany)